Candriam SCA’s Opko Health OPK Stock Holding History

Candriam SCA’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-654,601	Closed	-$818K	–	916
2022 Q4	$818K	Buy	654,601 +202,253	+45%	+$319K	0.01%	745
2022 Q3	$855K	Buy	+452,348	New	+$1.07M	0.01%	741

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Candriam SCA's OPK Position: Q1 2023 in Review

Candriam SCA sold out of Opko Health (OPK) in Q1 2023, closing a stake of 654,601 shares — an estimated $818K sold.

Candriam SCA first reported a position in OPK in Q3 2022 and held it in 2 quarters. The position peaked at $855K in Q3 2022. 227 funds tracked by Wall St. Rank hold OPK as of Q1 2023.

Candriam SCA reported no remaining Opko Health position as of Q1 2023 after selling out during the quarter.
Candriam SCA sold 654,601 Opko Health shares in Q1 2023, an estimated $818K.
Candriam SCA first reported a position in Opko Health in Q3 2022 and held it in 2 quarters.
Candriam SCA's Opko Health position peaked at $855K in Q3 2022.
227 funds tracked by Wall St. Rank held Opko Health as of Q1 2023.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.